Health System Builds Telehealth Network; Sees Great Return on Investment

Source: Healthcare Finance News, Erin McCann (5/22/12)

"Polycom, a video conference and communications company, is helping Saint Vincent Health System build a telehealth network by visually connecting healthcare professionals and patients in virtual environments across 26 facilities in Pennsylvania."

Healthcare Finance News, Erin McCann

Bluetooth-capable stethoscopes, allowing doctors to hear heart sounds from across the country, are just one innovation Saint Vincent Health System is using in its new telehealth network, which has reduced hospital readmissions and generated a 100 percent ROI in less than two months, officials say.

Pleasanton, Calif.-based Polycom, a video conference and communications company, is helping Saint Vincent Health System build a telehealth network with technology that seeks to make healthcare more accessible by visually connecting healthcare professionals and patients in virtual environments across 26 facilities in Pennsylvania. . .View Full Article

Biotech Firm Adjusts Placement Terms to Fuel U.S. Expansion
Source: Streetwise Reports (07/07/2025)

Canadian healthcare and clinical stage drug development company Algernon Pharmaceuticals Inc. (AGN:CSE; AGNPF:OTCQB; AGW0:XFRA) updates the pricing and warrant terms for its previously announced non-brokered private placement. Read why one technical analyst thinks the stock is ready to break out.

Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) launched its enhanced medical education suite in Minnesota, showing strong reliability and providing schools with up to 40% cost savings. Read on to find out how AI-simulated patients are reshaping medical education and enhancing clinical skills at scale.

Healthcare Firm Uncovers AI Healthcare Growth Opportunity
Source: Streetwise Reports (06/06/2025)

Treatment.com AI Inc.'s (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) subsidiary Rocket Doctor was chosen by the Larta Institute to participate in its Bioscience and Healthcare Accelerator program. Read on to learn why one analyst says it is time to buy this company's stock.

Co. Poised to Begin Major New Bull Market
Source: Clive Maund (05/23/2025)

Technical Analyst Clive Maund explains why he thinks Algernon Pharmaceuticals Inc. (AGN:CSE; AGNPF:OTCQB; AGW0:XFRA) is an Immediate Strong Buy.

Centrally Positioned AI Co. Platform Designed To Transform Healthcare
Source: Clive Maund (05/21/2025)

Technical Analyst Clive Maund explains why he thinks now is an excellent time to buy or add to positions in Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA).